 | • レポートコード：MRC2304A172 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、227ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年に1,015.39百万ドルであった世界の前臨床光学イメージング市場規模が2022年に1,158.66百万ドルに到達し、2027年までにCAGR 14.28％で成長して2,262.64百万ドルへと拡大すると予測しています。当調査資料では、前臨床光学イメージングの世界市場について多角的な視点から分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品タイプ別（消耗品、機器、ソフトウェア）分析、最終用途別（製薬＆バイオテクノロジー企業、研究機関）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目をまとめました。なお、当書内の企業情報としては、Agilent Technologies Inc.、Analytik Jena GmbH、Angstrom Advanced Inc、Aspect Imaging Ltd.、Berthold Technologies GmbH & Co.KG、Bruker Corporation、FUJIFILM Holdings Corporation、General Electric Company、INDEC Systems, Inc.などが掲載されています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の前臨床光学イメージング市場規模：製品タイプ別 - 消耗品の市場規模 - 機器の市場規模 - ソフトウェアの市場規模 ・世界の前臨床光学イメージング市場規模：最終用途別 - 製薬＆バイオテクノロジー企業における市場規模 - 研究機関における市場規模 ・世界の前臨床光学イメージング市場規模：地域別 - 南北アメリカの前臨床光学イメージング市場規模 アメリカの前臨床光学イメージング市場規模 カナダの前臨床光学イメージング市場規模 ブラジルの前臨床光学イメージング市場規模 ... - アジア太平洋の前臨床光学イメージング市場規模 日本の前臨床光学イメージング市場規模 中国の前臨床光学イメージング市場規模 インドの前臨床光学イメージング市場規模 韓国の前臨床光学イメージング市場規模 台湾の前臨床光学イメージング市場規模 ... - ヨーロッパ/中東/アフリカの前臨床光学イメージング市場規模 イギリスの前臨床光学イメージング市場規模 ドイツの前臨床光学イメージング市場規模 フランスの前臨床光学イメージング市場規模 ロシアの前臨床光学イメージング市場規模 ... - その他地域の前臨床光学イメージング市場規模 ・競争状況 ・企業情報 |
The Global Optical Preclinical Imaging Market size was estimated at USD 1,015.39 million in 2021 and expected to reach USD 1,158.66 million in 2022, and is projected to grow at a CAGR 14.28% to reach USD 2,262.64 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Optical Preclinical Imaging to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product Type, the market was studied across Consumables, Device, and Software. The Device is further studied across Bioluminescence and Fluorescence. The Bioluminescence is further studied across Coelenterazine, Luciferins, and Proluciferins. The Fluorescence is further studied across Green fluorescent proteins, Infrared dyes, and Red fluorescent proteins.
Based on End-use, the market was studied across Pharma & Biotech Companies and Research Institutes.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Optical Preclinical Imaging market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Optical Preclinical Imaging Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Optical Preclinical Imaging Market, including Agilent Technologies Inc., Analytik Jena GmbH, Angstrom Advanced Inc, Aspect Imaging Ltd., Berthold Technologies GmbH & Co.KG, Bruker Corporation, FUJIFILM Holdings Corporation, General Electric Company, INDEC Systems, Inc., LI-COR, Inc., Magnetic Insight, Inc., MBF Bioscience, Mediso Ltd., Milabs B.V., Miltenyi Biotec B.V. & Co. KG, Mirion Technologies (Capintec), Inc., MR Solutions Ltd, Northridge Tri-Modality Imaging, Inc., PerkinElmer Inc, Siemens A.G, Thermo Fisher Scientific Inc., and Vieworks Co., Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Optical Preclinical Imaging Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Optical Preclinical Imaging Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Optical Preclinical Imaging Market?
4. What is the competitive strategic window for opportunities in the Global Optical Preclinical Imaging Market?
5. What are the technology trends and regulatory frameworks in the Global Optical Preclinical Imaging Market?
6. What is the market share of the leading vendors in the Global Optical Preclinical Imaging Market?
7. What modes and strategic moves are considered suitable for entering the Global Optical Preclinical Imaging Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased use of preclinical imaging in different sectors
5.1.1.2. Growing number of clinical research organizations (CROs) and pharmaceutical companies thereby increasing the adoption of in-vivo imaging systems in preclinical research
5.1.1.3. Increasing use for imagining of living animals specifically for research purposes
5.1.2. Restraints
5.1.2.1. Lack of skilled research personnel in emerging economies
5.1.3. Opportunities
5.1.3.1. Technological advancement and increasing adoption of molecular imaging technology for drug development tool
5.1.3.2. Rising number of public-private initiatives and funding to support preclinical researches
5.1.3.3. Increasing applications such as life sciences, cosmetic industry and others for preclinical products
5.1.4. Challenges
5.1.4.1. Strict regulatory framework and high installation and operational costs associated with preclinical imaging
5.2. Cumulative Impact of COVID-19
6. Optical Preclinical Imaging Market, by Product Type
6.1. Introduction
6.2. Consumables
6.3. Device
6.4.1. Bioluminescence
6.4.2.1. Coelenterazine
6.4.2.2. Luciferins
6.4.2.3. Proluciferins
6.4.2. Fluorescence
6.4.3.1. Green fluorescent proteins
6.4.3.2. Infrared dyes
6.4.3.3. Red fluorescent proteins
6.4. Software
7. Optical Preclinical Imaging Market, by End-use
7.1. Introduction
7.2. Pharma & Biotech Companies
7.3. Research Institutes
8. Americas Optical Preclinical Imaging Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Optical Preclinical Imaging Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Optical Preclinical Imaging Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Agilent Technologies Inc.
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Analytik Jena GmbH
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Angstrom Advanced Inc
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Aspect Imaging Ltd.
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Berthold Technologies GmbH & Co.KG
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Bruker Corporation
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. FUJIFILM Holdings Corporation
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. General Electric Company
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. INDEC Systems, Inc.
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. LI-COR, Inc.
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Magnetic Insight, Inc.
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. MBF Bioscience
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. Mediso Ltd.
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Milabs B.V.
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Miltenyi Biotec B.V. & Co. KG
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Mirion Technologies (Capintec), Inc.
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. MR Solutions Ltd
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Northridge Tri-Modality Imaging, Inc.
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. PerkinElmer Inc
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Siemens A.G
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Thermo Fisher Scientific Inc.
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. Vieworks Co., Ltd.
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing